What conditions are considered high-risk for developing infective endocarditis, including prosthetic valves, atrial septal defect, history of infective endocarditis, bypass surgery, and congenital heart disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

High-Risk Conditions for Infective Endocarditis

Based on current ACC/AHA and ESC guidelines, the conditions at highest risk for infective endocarditis are: (a) prosthetic valves, (c) history of infective endocarditis, and (e) specific types of congenital heart disease—NOT atrial septal defect or bypass surgery alone. 1

Conditions Considered High-Risk

a. Prosthetic Valves - YES, High Risk

  • Patients with prosthetic cardiac valves (mechanical, biological, surgical, or transcatheter) or prosthetic material used for valve repair are definitively at highest risk 1
  • These patients have higher mortality from IE and develop complications more frequently than those with native valves 1
  • The 1-year mortality from IE in prosthetic valve patients can reach 75% 2

b. Atrial Septal Defect - NO, Not High Risk

  • Isolated secundum atrial septal defect is explicitly excluded from high-risk categories 1
  • Patients 6 months or more after successful surgical or percutaneous ASD repair do not require prophylaxis 1
  • Current guidelines specifically state that antibiotic prophylaxis is no longer recommended for simple ASDs 1

c. History of Infective Endocarditis - YES, High Risk

  • Previous IE is consistently identified as a highest-risk condition across all major guidelines 1
  • The cumulative risk of recurrent IE at 10 years is 8.8% in patients with prior IE 3
  • These patients have a 65-fold increased risk compared to matched controls 3

d. Bypass Surgery - NO, Not High Risk

  • Coronary artery bypass surgery alone does not place patients at high risk for IE 1
  • Bypass grafts are not considered cardiac conditions requiring prophylaxis 1
  • This is distinct from surgically constructed systemic-pulmonary shunts in congenital heart disease, which ARE high-risk 1

e. Congenital Heart Disease - DEPENDS on Specific Type

High-risk CHD includes: 1

  • Unrepaired cyanotic CHD, including palliative shunts and conduits
  • Completely repaired CHD with prosthetic material or device (surgery or catheter) during the first 6 months post-procedure
  • Repaired CHD with residual defects at or adjacent to prosthetic patches or devices that inhibit endothelialization
  • Complex cyanotic lesions (single ventricle, transposition, tetralogy of Fallot)

NOT high-risk CHD: 1

  • Isolated secundum ASD
  • Successfully repaired VSD, ASD, or PDA beyond 6 months without residual defects
  • Bicuspid aortic valve without stenosis or regurgitation (though this remains controversial in practice) 1

Clinical Implications

The 10-year cumulative risk of IE varies significantly: 3

  • Prior IE: 8.8%
  • Prosthetic valve: 6.0%
  • Complex CHD: 1.3%

Common pitfall: Many physicians continue to provide prophylaxis for conditions no longer considered high-risk (such as mitral valve prolapse, bicuspid aortic valve, or simple repaired CHD), which is not supported by current evidence and exposes patients to unnecessary antibiotic risks 1, 4

Prophylaxis is reasonable only for high-risk patients undergoing dental procedures involving gingival manipulation or periapical region manipulation—NOT for GI, GU, or respiratory procedures 1, 5

Answer Summary

High-risk conditions: a, c, and specific types of e

Not high-risk: b and d

The shift in guidelines reflects that prophylaxis should target only those with the highest risk of adverse outcomes from IE, not simply those with any lifetime risk of developing IE 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Prophylaxis After TAVI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Infective endocarditis prophylaxis in congenital heart disease].

Presse medicale (Paris, France : 1983), 2017

Guideline

Prophylaxis for Transgastric Biopsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Which patients require antibiotic prophylaxis for endocarditis in dental procedures?
What are the diagnostic criteria and treatment options for endocarditis in elderly patients?
What is the recommended antibiotic prophylaxis for preventing endocarditis (infection of the inner lining of the heart) following a root canal procedure?
For which of the following cardiac lesions is endocarditis prophylaxis not advised before dental procedures: completely repaired congenital heart defects during the 6 months after repair, valve stenosis on echocardiography, left ventricular assist devices (LVAD) or implantable heart devices, or surgical or transcatheter pulmonary artery valve or conduit placement?
Under what circumstances is antibiotic prophylaxis (use of antibiotics to prevent infection) recommended before dental work?
What is the recommended treatment and duration of antibiotics for a patient with typhoid salmonella, considering factors such as disease severity, medical history, age, weight, and renal function?
What is the mechanism of rectal bleeding in elderly or critically ill patients with limited mobility and significant medical histories, including potential neurological disorders or post-surgical complications, using Fecal Management Systems (FMS)?
What is the recommended renal dose adjustment for metformin in a patient with impaired renal function?
What should be done for an adult patient with a history of urinary tract infections, currently on tazobactam (piperacillin/tazobactam), who develops leukocytosis and has mild pyuria?
What are the differences between atopic dermatitis (eczema) and psoriasis in terms of symptoms, treatment, and patient management?
What are the treatment options for a patient with pulmonary hypertension, how does sildenafil (phosphodiesterase-5 inhibitor) work, and when should they be referred to a specialist, particularly if they have a history of heart failure or impaired cardiac function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.